PN40082

DEVICE3 trials

Sponsors

Prollenium Medical Technologies Inc.

Conditions

Lip Augmentation

Phase 3

A Multicenter, Double-blind, Randomized, Controlled, Roll-over Retreatment Study of the Safety and Pain Associated With Injections of PN40082, RV001 With Topical Anesthetic or RV001 for Lip Augmentation

TerminatedNCT04029545

Prollenium Medical Technologies Inc.Lip Augmentation

Start: 2019-06-14End: 2019-12-09Updated: 2021-08-20

A Multicenter, Open-Label Retreatment Study of the Safety and Effectiveness of PN40082 for Lip Augmentation

CompletedNCT04029519

Prollenium Medical Technologies Inc.Lip Augmentation

Start: 2018-12-21End: 2019-08-27Updated: 2021-07-14

Unknown Phase

Safety and Effectiveness of PN40082 for Lip Augmentation

CompletedNCT04032977

Prollenium Medical Technologies Inc.Lip Augmentation

Start: 2018-07-13End: 2019-05-03Updated: 2021-07-12